Palbociclib

Palbociclib

Cat. No.: PI571190302

Description: Palbociclib is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Palbociclib was the first CDK4/6 inhibitor to be approved as a cancer therapy.

Product Details
CAS 571190-30-2
Trade Names Ibrance
Molecular Formula C24H29N7O2
Molecular Weight 447.533
Available Formulations Oral Solid
Technology Synthetic
Available DMF/CEP/GMP US DMF

* Our products are for research use only.

Get in Touch

We’re glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to inquiry@alfa-chemistry.com or fill out the following form.

Verification code
For product and service inquiries icon1

For product and service inquiries, please use our online system or send an email to inquiry@alfa-chemistry.com.

For product and service inquiries icon2

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x